Cubresa at the Third Annual MPIC Meeting in Nashville Reveal disease & therapeutic mechanisms with simultaneous molecular & functional imaging As an industry sponsor of the 3rd Annual Midwest Preclinical Imaging Consortium (MPIC), we enjoyed meeting all the attendees while in Nashville at the meeting. We will be pleased to speak with you to show you how our NuPET™ in-bore PET…
10 am on Friday, May 15th in the Searle Seminar Room at the Robert H. Lurie Medical Research Center Cubresa held a seminar on Simultaneous Molecular & Functional Imaging with the Cubresa NuPET™ MR-compatible preclinical PET scanner at Northwestern University at 10 am on Friday, May 12th in the Searle Seminar Room at the Robert H. Lurie…
Come see Cubresa’s NuPET™ in Booth 125 at the ISMRM 2017 Annual Meeting & Exhibition in Honolulu Reveal disease & therapeutic mechanisms with simultaneous molecular & functional imaging We certainly enjoyed our time at this year’s International Society for Magnetic Resonance in Medicine in Honolulu, April 22 to 27, 2017 where we showcased our NuPET™ in-bore PET scanner for existing pre-clinical…
Thank you for coming to see Cubresa’s NuPET™ at the EMIM 2017 Meeting & Exhibition in Cologne Reveal disease & therapeutic mechanisms with simultaneous molecular & functional imaging This year’s European Molecular Imaging Meeting at Hörsaalgebäude University in Cologne, April 5 to 7, 2017 was a very successful showcase for our NuPET™ in-bore PET scanner for existing pre-clinical MRI systems. The…
Cubresa’s SPECT scanner was used to determine if a novel molecular label, TRV6001, in development for in vivo imaging of the BChE enzyme present in the brains of Alzheimer’s Disease patients follows the known distribution of the enzyme in animal models of the disease. Winnipeg, MB – November 22, 2016 – Cubresa Inc., a medical…
Simultaneous imaging with complementary modalities: PET & MRI If you missed our free webinar on Thursday, November 10th, you can request a link to view the recording, where you can learn how PET and MRI complement each other, and how one customer, Dr. Marty Pagel of the University of Arizona, is developing a dual-modality approach…
Cubresa’s new, larger headquarters will open for business at the following address on Tuesday September 6, 2016: Cubresa Inc. 801 Berry Street Winnipeg, MB R3H 0S7 Our telephone and facsimile numbers, as well as our e-mail addresses and web address, will remain the same. We look forward to fully utilizing our improved headquarters for research &…
Dual-modality approach being developed by the University of Arizona uses Cubresa’s NuPET™ PET scanner and a dynamic MRI technique to more fully characterize cancerous tumors. Winnipeg, MB – September 1, 2016 – Cubresa Inc., a medical imaging company that develops and markets molecular imaging systems, today announced the successful installation of their compact PET scanner called NuPET™ for…
Halifax, NS – August 5, 2016 – BIOTIC (Biomedical Translational Imaging Centre), the advanced imaging center at the IWK Health Centre, has been chosen as the first research facility to test a new preclinical PET (Positron Emission Tomography) scanner. Cubresa, a medical imaging company that develops and markets nuclear imaging systems, has developed NuPET™, a…
Cubresa is a world leader in the design and development of clinical and preclinical PET inserts for MRI. Cubresa products enable medical professionals at leading universities, hospitals and pharmaceutical companies to visualize and measure biochemical processes at the molecular level.
About Us
Leadership
Technology
Careers
Cubresa Inc.
800-136 Market Ave
Winnipeg, MB, Canada
R3B 0P4